Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases
Fintech investor Nyca Partners is back in the fundraising market with the successor to its $210m third fund closed two years ago. The post Fintech investor Nyca Partners back fundraising with follow-up to $210m Fund
Tech companies are growing up and spreading out, creating what is London’s new “Tech Belt”
Recent Comments